LeMaitre Vascular: The Compounder Keeps Compounding
2026-02-27 15:01:26 ET
I last covered LeMaitre Vascular (NASDAQ:LMAT) at $81 in June 2025 , reiterating my Buy rating. Eight months later, shares are up about 35%, more than double that of the broader market. The stock jumped ~20% alone on the recent Q4 beat and raise, with 2026 guidance coming in 13% above Wall Street’s consensus. Pricing power, operating leverage, and international growth were all contributors....
Read the full article on Seeking Alpha
For further details see:
LeMaitre Vascular: The Compounder Keeps CompoundingNASDAQ: SYK
SYK Trading
-3.76% G/L:
$348.645 Last:
2,146,791 Volume:
$358.49 Open:



